Annual Revenue
$644.39 M
+$145.41 M+29.14%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual revenue is currently $644.39 million, with the most recent change of +$145.41 million (+29.14%) on 31 December 2023. During the last 3 years, it has risen by +$294.55 million (+84.19%). AMPH annual revenue is now at all-time high.AMPH Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$191.21 M
+$8.82 M+4.84%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly revenue is currently $191.21 million, with the most recent change of +$8.82 million (+4.84%) on 30 September 2024. Over the past year, it has increased by +$10.66 million (+5.90%). AMPH quarterly revenue is now at all-time high.AMPH Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$723.55 M
+$10.66 M+1.50%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM revenue is currently $723.55 million, with the most recent change of +$10.66 million (+1.50%) on 30 September 2024. Over the past year, it has increased by +$122.24 million (+20.33%). AMPH TTM revenue is now at all-time high.AMPH TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.1% | +5.9% | +20.3% |
| 3 y3 years | +84.2% | +70.4% | +75.3% |
| 5 y5 years | +118.7% | +138.6% | +120.2% |
AMPH Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +84.2% | at high | +70.4% | at high | +75.3% |
| 5 y | 5 years | at high | +118.7% | at high | +138.6% | at high | +124.5% |
| alltime | all time | at high | +444.4% | at high | +316.9% | at high | +1266.1% |
Amphastar Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $191.21 M(+4.8%) | $723.55 M(+1.5%) |
| June 2024 | - | $182.39 M(+6.1%) | $712.89 M(+5.4%) |
| Mar 2024 | - | $171.84 M(-3.5%) | $676.21 M(+4.9%) |
| Dec 2023 | $644.39 M(+29.1%) | $178.10 M(-1.4%) | $644.39 M(+7.2%) |
| Sept 2023 | - | $180.56 M(+23.9%) | $601.31 M(+11.2%) |
| June 2023 | - | $145.71 M(+4.1%) | $540.89 M(+4.3%) |
| Mar 2023 | - | $140.02 M(+3.7%) | $518.64 M(+3.9%) |
| Dec 2022 | $498.99 M(+14.0%) | $135.02 M(+12.4%) | $498.99 M(+2.9%) |
| Sept 2022 | - | $120.13 M(-2.7%) | $484.85 M(+1.7%) |
| June 2022 | - | $123.47 M(+2.6%) | $476.92 M(+4.8%) |
| Mar 2022 | - | $120.37 M(-0.4%) | $455.12 M(+4.0%) |
| Dec 2021 | $437.77 M(+25.1%) | $120.89 M(+7.7%) | $437.77 M(+6.0%) |
| Sept 2021 | - | $112.20 M(+10.4%) | $412.80 M(+7.5%) |
| June 2021 | - | $101.66 M(-1.3%) | $384.04 M(+4.3%) |
| Mar 2021 | - | $103.02 M(+7.4%) | $368.18 M(+5.2%) |
| Dec 2020 | $349.85 M(+8.5%) | $95.92 M(+15.0%) | $349.85 M(+3.7%) |
| Sept 2020 | - | $83.43 M(-2.8%) | $337.31 M(+1.0%) |
| June 2020 | - | $85.81 M(+1.3%) | $334.01 M(+2.1%) |
| Mar 2020 | - | $84.69 M(+1.6%) | $327.25 M(+1.5%) |
| Dec 2019 | $322.36 M(+9.4%) | $83.38 M(+4.1%) | $322.36 M(-1.9%) |
| Sept 2019 | - | $80.14 M(+1.4%) | $328.66 M(+1.4%) |
| June 2019 | - | $79.05 M(-0.9%) | $324.07 M(+2.5%) |
| Mar 2019 | - | $79.79 M(-11.0%) | $316.06 M(+7.3%) |
| Dec 2018 | $294.67 M | $89.69 M(+18.7%) | $294.67 M(+11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $75.54 M(+6.3%) | $265.38 M(+7.1%) |
| June 2018 | - | $71.04 M(+21.7%) | $247.75 M(+2.4%) |
| Mar 2018 | - | $58.39 M(-3.3%) | $241.90 M(+0.7%) |
| Dec 2017 | $240.18 M(-5.9%) | $60.40 M(+4.3%) | $240.18 M(-1.3%) |
| Sept 2017 | - | $57.92 M(-11.2%) | $243.32 M(-2.5%) |
| June 2017 | - | $65.19 M(+15.0%) | $249.62 M(-1.1%) |
| Mar 2017 | - | $56.67 M(-10.8%) | $252.47 M(-1.1%) |
| Dec 2016 | $255.16 M(+1.4%) | $63.54 M(-1.1%) | $255.16 M(-5.0%) |
| Sept 2016 | - | $64.22 M(-5.6%) | $268.53 M(+0.1%) |
| June 2016 | - | $68.03 M(+14.6%) | $268.18 M(+5.6%) |
| Mar 2016 | - | $59.37 M(-22.8%) | $254.00 M(+1.0%) |
| Dec 2015 | $251.52 M(+19.5%) | $76.91 M(+20.4%) | $251.52 M(+9.1%) |
| Sept 2015 | - | $63.87 M(+18.6%) | $230.48 M(+1.8%) |
| June 2015 | - | $53.85 M(-5.3%) | $226.33 M(+2.2%) |
| Mar 2015 | - | $56.89 M(+1.8%) | $221.48 M(+5.2%) |
| Dec 2014 | $210.46 M(-8.4%) | $55.88 M(-6.4%) | $210.46 M(+0.5%) |
| Sept 2014 | - | $59.71 M(+21.9%) | $209.46 M(+0.2%) |
| June 2014 | - | $49.00 M(+6.8%) | $209.07 M(-6.1%) |
| Mar 2014 | - | $45.87 M(-16.4%) | $222.59 M(-3.1%) |
| Dec 2013 | $229.68 M(+12.4%) | $54.88 M(-7.5%) | $229.68 M(+31.4%) |
| Sept 2013 | - | $59.32 M(-5.1%) | $174.81 M(+51.4%) |
| June 2013 | - | $62.52 M(+18.1%) | $115.49 M(+118.1%) |
| Mar 2013 | - | $52.96 M | $52.96 M |
| Dec 2012 | $204.32 M(+72.6%) | - | - |
| Dec 2011 | $118.36 M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual revenue year-on-year change?
- What is Amphastar Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly revenue year-on-year change?
- What is Amphastar Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM revenue year-on-year change?
What is Amphastar Pharmaceuticals annual revenue?
The current annual revenue of AMPH is $644.39 M
What is the all time high annual revenue for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual revenue is $644.39 M
What is Amphastar Pharmaceuticals annual revenue year-on-year change?
Over the past year, AMPH annual revenue has changed by +$145.41 M (+29.14%)
What is Amphastar Pharmaceuticals quarterly revenue?
The current quarterly revenue of AMPH is $191.21 M
What is the all time high quarterly revenue for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly revenue is $191.21 M
What is Amphastar Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, AMPH quarterly revenue has changed by +$10.66 M (+5.90%)
What is Amphastar Pharmaceuticals TTM revenue?
The current TTM revenue of AMPH is $723.55 M
What is the all time high TTM revenue for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM revenue is $723.55 M
What is Amphastar Pharmaceuticals TTM revenue year-on-year change?
Over the past year, AMPH TTM revenue has changed by +$122.24 M (+20.33%)